Expected earnings - Boundless Bio Inc.
Source: US Earnings Reports
Boundless Bio Inc. (BOLD) is expected to report $-0.44 for Q4 2025
Audentes Therapeutics Inc.
NASDAQ: BOLD
BOLD Trading
-1.32% G/L:
$1.12 Last:
33,542 Volume:
$1.13 Open:
BOLD Latest News
BOLD Stock Data
$25,819,564
17,662,247
6.34%
6
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
